These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28955487)

  • 1. Validation of the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis by disease content experts.
    Yates M; Watts R; Bajema I; Cid M; Crestani B; Hauser T; Hellmich B; Holle J; Laudien M; Little MA; Luqmani RA; Mahr A; Merkel P; Mills J; Mooney J; Segelmark M; Tesar V; Westman KWA; Vaglio A; Yalçındağ N; Jayne DR; Mukhtyar C
    RMD Open; 2017; 3(1):e000449. PubMed ID: 28955487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis.
    Yates M; Watts RA; Bajema IM; Cid MC; Crestani B; Hauser T; Hellmich B; Holle JU; Laudien M; Little MA; Luqmani RA; Mahr A; Merkel PA; Mills J; Mooney J; Segelmark M; Tesar V; Westman K; Vaglio A; Yalçındağ N; Jayne DR; Mukhtyar C
    Ann Rheum Dis; 2016 Sep; 75(9):1583-94. PubMed ID: 27338776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of antineutrophil cytoplasmic antibody-associated vasculitis: a review of recent guidelines.
    Ahn SS; Lee SW
    J Rheum Dis; 2023 Apr; 30(2):72-87. PubMed ID: 37483479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force.
    Mukhtyar C; Flossmann O; Hellmich B; Bacon P; Cid M; Cohen-Tervaert JW; Gross WL; Guillevin L; Jayne D; Mahr A; Merkel PA; Raspe H; Scott D; Witter J; Yazici H; Luqmani RA;
    Ann Rheum Dis; 2008 Jul; 67(7):1004-10. PubMed ID: 17911225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab in ANCA-Associated Vasculitis.
    Hassan RI; Gaffo AL
    Curr Rheumatol Rep; 2017 Feb; 19(2):6. PubMed ID: 28155022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of vasculitides: according to recommendations of the European League Against Rheumatism (EULAR) and European Vasculitis Study Group (EUVAS)].
    Holle JU; Moosig F; Gross WL; ;
    Internist (Berl); 2011 Jun; 52(6):671-81. PubMed ID: 21512793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long term azathioprine maintenance therapy in ANCA-associated vasculitis: combined results of long-term follow-up data.
    de Joode AAE; Sanders JSF; Puéchal X; Guillevin LP; Hiemstra TF; Flossmann O; Rasmussen N; Westman K; Jayne DR; Stegeman CA
    Rheumatology (Oxford); 2017 Nov; 56(11):1894-1901. PubMed ID: 28977502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2017 Clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management of ANCA-associated vasculitis.
    Harigai M; Nagasaka K; Amano K; Bando M; Dobashi H; Kawakami T; Kishibe K; Murakawa Y; Usui J; Wada T; Tanaka E; Nango E; Nakayama T; Tsutsumino M; Yamagata K; Homma S; Arimua Y
    Mod Rheumatol; 2019 Jan; 29(1):20-30. PubMed ID: 30001655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial.
    Hiemstra TF; Walsh M; Mahr A; Savage CO; de Groot K; Harper L; Hauser T; Neumann I; Tesar V; Wissing KM; Pagnoux C; Schmitt W; Jayne DR;
    JAMA; 2010 Dec; 304(21):2381-8. PubMed ID: 21060104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommendations of the Brazilian Society of Rheumatology for the induction therapy of ANCA-associated vasculitis.
    Souza AWS; Calich AL; Mariz HA; Ochtrop MLG; Bacchiega ABS; Ferreira GA; Rêgo J; Perez MO; Pereira RMR; Bernardo WM; Levy RA
    Rev Bras Reumatol Engl Ed; 2017; 57 Suppl 2():484-496. PubMed ID: 28754431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and Outcomes of Granulomatosis With Polyangiitis (Wegener) and Microscopic Polyangiitis Requiring Renal Replacement Therapy: Results From the European Renal Association-European Dialysis and Transplant Association Registry.
    Hruskova Z; Stel VS; Jayne D; Aasarød K; De Meester J; Ekstrand A; Eller K; Heaf JG; Hoitsma A; Martos Jimenéz C; Ravani P; Wanner C; Tesar V; Jager KJ
    Am J Kidney Dis; 2015 Oct; 66(4):613-20. PubMed ID: 25975963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ANCA-Associated Vasculitis: Core Curriculum 2020.
    Geetha D; Jefferson JA
    Am J Kidney Dis; 2020 Jan; 75(1):124-137. PubMed ID: 31358311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab for remission induction in elderly patients with ANCA-associated vasculitis.
    Timlin H; Lee SM; Manno RL; Seo P; Geetha D
    Semin Arthritis Rheum; 2015 Aug; 45(1):67-9. PubMed ID: 25796088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current landscape of antineutrophil cytoplasmic antibody-associated vasculitis: classification, diagnosis, and treatment.
    Lally L; Spiera R
    Rheum Dis Clin North Am; 2015; 41(1):1-19, vii. PubMed ID: 25399936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of severity classification in Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort study.
    Sada KE; Harigai M; Amano K; Atsumi T; Fujimoto S; Yuzawa Y; Takasaki Y; Banno S; Sugihara T; Kobayashi M; Usui J; Yamagata K; Homma S; Dobashi H; Tsuboi N; Ishizu A; Sugiyama H; Okada Y; Arimura Y; Matsuo S; Makino H;
    Mod Rheumatol; 2016 Sep; 26(5):730-7. PubMed ID: 26873424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive Granulomatosis With Polyangiitis (Wegener's) Is a Clinically Distinct Subset of ANCA-Associated Vasculitis: A Retrospective Analysis of 315 Patients From a German Vasculitis Referral Center.
    Schirmer JH; Wright MN; Herrmann K; Laudien M; Nölle B; Reinhold-Keller E; Bremer JP; Moosig F; Holle JU
    Arthritis Rheumatol; 2016 Dec; 68(12):2953-2963. PubMed ID: 27333332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Autoimmune vasculitides. Standards and guidelines of EULAR and EUVAS].
    Moosig F; Holle JU; Gross WL;
    Internist (Berl); 2009 Mar; 50(3):298-309. PubMed ID: 19198789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recommendations on the use of rituximab for ANCA-associated vasculitis].
    Gause AM; Rubbert-Roth A;
    Z Rheumatol; 2014 Apr; 73(3):287-9. PubMed ID: 27039911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remission maintenance in ANCA-associated vasculitis: does one size fit all?
    Berti A; Specks U
    Expert Rev Clin Immunol; 2019 Dec; 15(12):1273-1286. PubMed ID: 31762340
    [No Abstract]   [Full Text] [Related]  

  • 20. "How I treat" autoimmune diseases: State of the art on the management of rare rheumatic diseases and ANCA-associated systemic idiopathic vasculitis.
    Roccatello D
    Autoimmun Rev; 2017 Oct; 16(10):995-998. PubMed ID: 28780080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.